Electra Therapeutics, Inc. (ETRA) insider trading
Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 10, 2026.
- Filings shown
- 10
- Open-market buys
- 36
- Open-market sells
- 0
- Buys, 10b5-1 box not checked
- 36 of 36
Counts cover the 10 most recent Form 4 filings Tradune holds for ETRA (filed Sep 21 – Nov 10, 2026). SEC EDGAR Form 4 filings for ETRA last checked Nov 21, 2026, 09:00 UTC; the latest ETRA filing Tradune holds was filed Nov 10, 2026. This is not guaranteed to be the complete record — see ETRA's full Form 4 filing history on SEC EDGAR.
Open-market activity, last 90 days
Purchases (Form 4 code P) and sales (code S) on the 10 filings Tradune holds for ETRA filed Sep 21 – Nov 10, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.
| Insider | Buys | Sells | Shares bought | Shares sold | Value |
|---|---|---|---|---|---|
| Carl L. GordonDirector, 10% owner | 18 | 0 | 1,898,020 | — | +$24,349,642 |
| Orbimed Advisors LLCDirector, 10% owner | 18 | 0 | 1,898,020 | — | +$24,349,642 |
Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.
Insider-activity score
56/ 100
Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →
Get alerted when insiders buy the stocks you own
Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.
Free for everyone right now · no card · nothing to buy
Weekly signal history
ETRA appeared in 1 archived weekly edition as a multi-insider cluster, a top net buyer, or both. These are frozen weekly snapshots, not a complete filing history.
- Week of Nov 10, 2026 2 insiders buying · $7,210,233 net
An entry means this company met that edition’s displayed cluster or top-buyer threshold. Missing weeks do not mean no insider transaction occurred. All figures are derived from SEC Form 4 filings; open-market buys minus sales are shown as net only when every transaction value was disclosed.
How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).
Insider Buying at ETRA
Insiders reported 36 open-market purchases of ETRA in the trailing 90 days, across 2 distinct buyers. The most recent purchase was reported by Orbimed Advisors LLC (Director, 10% owner) on Nov 10, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Recent Form 4 filings
Source: SEC EDGAR Form 4 · transaction codes explained
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 20,700 | $8.45 | 5,255,278 (indirect) | +0.4% | Nov 10, 2026 |
| Open-market purchase 10b5-1 box not checked | 2,000 | $8.45 | 2,194,579 (indirect) | +0.1% | Nov 10, 2026 |
| Open-market purchase 10b5-1 box not checked | 4,000 | $8.24 | 5,234,578 (indirect) | +0.1% | Nov 9, 2026 |
| Open-market purchase 10b5-1 box not checked | 16,000 | $8.24 | 2,192,579 (indirect) | +0.7% | Nov 9, 2026 |
| Open-market purchase 10b5-1 box not checked | 9,816 | $7.85 | 5,230,578 (indirect) | +0.2% | Nov 6, 2026 |
| Open-market purchase 10b5-1 box not checked | 39,600 | $7.85 | 2,176,579 (indirect) | +1.9% | Nov 6, 2026 |
† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.
“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 2,000 | $8.45 | 2,194,579 (indirect) | +0.1% | Nov 10, 2026 |
| Open-market purchase 10b5-1 box not checked | 20,700 | $8.45 | 5,255,278 (indirect) | +0.4% | Nov 10, 2026 |
| Open-market purchase 10b5-1 box not checked | 4,000 | $8.24 | 5,234,578 (indirect) | +0.1% | Nov 9, 2026 |
| Open-market purchase 10b5-1 box not checked | 16,000 | $8.24 | 2,192,579 (indirect) | +0.7% | Nov 9, 2026 |
| Open-market purchase 10b5-1 box not checked | 9,816 | $7.85 | 5,230,578 (indirect) | +0.2% | Nov 6, 2026 |
| Open-market purchase 10b5-1 box not checked | 39,600 | $7.85 | 2,176,579 (indirect) | +1.9% | Nov 6, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 30,891 | $7.31 | 5,220,762 (indirect) | +0.6% | Nov 5, 2026 |
| Open-market purchase 10b5-1 box not checked | 125,200 | $7.31 | 2,136,979 (indirect) | +6.2% | Nov 5, 2026 |
| Open-market purchase 10b5-1 box not checked | 37,100 | $7.78 | 1,991,779 (indirect) | +1.9% | Nov 4, 2026 |
| Open-market purchase 10b5-1 box not checked | 20,000 | $7.07 | 2,011,779 (indirect) | +1.0% | Nov 4, 2026 |
| Open-market purchase 10b5-1 box not checked | 9,267 | $7.78 | 5,184,871 (indirect) | +0.2% | Nov 4, 2026 |
| Open-market purchase 10b5-1 box not checked | 5,000 | $7.07 | 5,189,871 (indirect) | +0.1% | Nov 4, 2026 |
| Open-market purchase 10b5-1 box not checked | 97,800 | $7.84 | 1,856,079 (indirect) | +5.6% | Nov 3, 2026 |
| Open-market purchase 10b5-1 box not checked | 24,313 | $7.84 | 5,151,204 (indirect) | +0.5% | Nov 3, 2026 |
| Open-market purchase 10b5-1 box not checked | 24,400 | $7.88 | 5,175,604 (indirect) | +0.5% | Nov 3, 2026 |
| Open-market purchase 10b5-1 box not checked | 98,600 | $7.88 | 1,954,679 (indirect) | +5.3% | Nov 3, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 30,891 | $7.31 | 5,220,762 (indirect) | +0.6% | Nov 5, 2026 |
| Open-market purchase 10b5-1 box not checked | 125,200 | $7.31 | 2,136,979 (indirect) | +6.2% | Nov 5, 2026 |
| Open-market purchase 10b5-1 box not checked | 9,267 | $7.78 | 5,184,871 (indirect) | +0.2% | Nov 4, 2026 |
| Open-market purchase 10b5-1 box not checked | 37,100 | $7.78 | 1,991,779 (indirect) | +1.9% | Nov 4, 2026 |
| Open-market purchase 10b5-1 box not checked | 5,000 | $7.07 | 5,189,871 (indirect) | +0.1% | Nov 4, 2026 |
| Open-market purchase 10b5-1 box not checked | 20,000 | $7.07 | 2,011,779 (indirect) | +1.0% | Nov 4, 2026 |
| Open-market purchase 10b5-1 box not checked | 24,313 | $7.84 | 5,151,204 (indirect) | +0.5% | Nov 3, 2026 |
| Open-market purchase 10b5-1 box not checked | 97,800 | $7.84 | 1,856,079 (indirect) | +5.6% | Nov 3, 2026 |
| Open-market purchase 10b5-1 box not checked | 24,400 | $7.88 | 5,175,604 (indirect) | +0.5% | Nov 3, 2026 |
| Open-market purchase 10b5-1 box not checked | 98,600 | $7.88 | 1,954,679 (indirect) | +5.3% | Nov 3, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Conversion of derivative Series C Convertible Preferred Stock | 758,279 | — | — | — | Sep 21, 2026 |
| Conversion of derivative | 1,087,934 | — | 3,090,244 (indirect) | +54% | Sep 21, 2026 |
| Conversion of derivative | 1,703,314 | — | 4,793,558 (indirect) | +55% | Sep 21, 2026 |
| Open-market purchase 10b5-1 box not checked | 333,333 | $15.00 | 5,126,891 (indirect) | +7.0% | Sep 21, 2026 |
| Conversion of derivative | 758,279 | — | 758,279 (indirect) | — | Sep 21, 2026 |
| Open-market purchase 10b5-1 box not checked | 1,000,000 | $15.00 | 1,758,279 (indirect) | +132% | Sep 21, 2026 |
| Conversion of derivative Series A Convertible Preferred Stock | 2,002,310 | — | — | — | Sep 21, 2026 |
| Conversion of derivative Series B Convertible Preferred Stock | 1,087,934 | — | — | — | Sep 21, 2026 |
| Conversion of derivative Series C Convertible Preferred Stock | 1,703,314 | — | — | — | Sep 21, 2026 |
| Conversion of derivative | 2,002,310 | — | 2,002,310 (indirect) | — | Sep 21, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Conversion of derivative | 2,002,310 | — | 2,002,310 (indirect) | — | Sep 21, 2026 |
| Conversion of derivative | 1,087,934 | — | 3,090,244 (indirect) | +54% | Sep 21, 2026 |
| Conversion of derivative | 1,703,314 | — | 4,793,558 (indirect) | +55% | Sep 21, 2026 |
| Open-market purchase 10b5-1 box not checked | 333,333 | $15.00 | 5,126,891 (indirect) | +7.0% | Sep 21, 2026 |
| Conversion of derivative | 758,279 | — | 758,279 (indirect) | — | Sep 21, 2026 |
| Open-market purchase 10b5-1 box not checked | 1,000,000 | $15.00 | 1,758,279 (indirect) | +132% | Sep 21, 2026 |
| Conversion of derivative Series A Convertible Preferred Stock | 2,002,310 | — | — | — | Sep 21, 2026 |
| Conversion of derivative Series B Convertible Preferred Stock | 1,087,934 | — | — | — | Sep 21, 2026 |
| Conversion of derivative Series C Convertible Preferred Stock | 1,703,314 | — | — | — | Sep 21, 2026 |
| Conversion of derivative Series C Convertible Preferred Stock | 758,279 | — | — | — | Sep 21, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Conversion of derivative | 85,504 | — | 85,504 | — | Sep 21, 2026 |
| Conversion of derivative Series A Convertible Preferred Stock | 85,504 | — | — | — | Sep 21, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Conversion of derivative | 63,656 | — | 63,656 | — | Sep 21, 2026 |
| Conversion of derivative Series A Convertible Preferred Stock | 63,656 | — | — | — | Sep 21, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Conversion of derivative | 455,484 | — | 455,484 | — | Sep 21, 2026 |
| Conversion of derivative Series A Convertible Preferred Stock | 455,484 | — | — | — | Sep 21, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Conversion of derivative Series A Convertible Preferred Stock | 255,635 | — | — | — | Sep 21, 2026 |
| Conversion of derivative | 255,635 | — | 255,635 | — | Sep 21, 2026 |
Insider filings reported around the same time
Other companies whose most recent Form 4 was filed closest to ETRA's (Nov 10, 2026).
Frequently asked about ETRA insider activity
How many insiders bought ETRA stock in the last 90 days?
2 distinct insiders at Electra Therapeutics, Inc. reported 36 open-market purchases (Form 4 code P) of ETRA shares in the trailing 90 days, the most recent filed by Orbimed Advisors LLC (Director, 10% owner) on Nov 10, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Who filed the most recent Form 4 for ETRA?
The most recent Form 4 on this page was filed by Orbimed Advisors LLC (Director, 10% owner) on Nov 10, 2026, reporting 6 transactions. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.
What was the largest open-market ETRA insider purchase shown?
The largest open-market purchase among the filings shown was 1,000,000 ETRA shares at $15.00 (about $15,000,000) by Carl L. Gordon (Director, 10% owner) on Sep 21, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.
Do the recent ETRA insider purchases have the Form 4 10b5-1 box checked?
No. All 36 ETRA open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Orbimed Advisors LLC (Director, 10% owner) on Nov 10, 2026, 20,700 shares.
New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.
Get insider alerts for ETRA — and your whole portfolio
Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy
This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.
Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.